The effect of nondipper blood pressure pattern on target organ damage in patients with metabolic syndrome;Metabolik sendromlu hastalarda nondipper kan basinci seyrinin hedef organ hasari üzerine etkisi

Turk Kardiyoloji Dernegi Arsivi

Volumn 37, Issue 7, 2009, Pages 454-460

  Soylu, Ahmet ^a   Güleç, Hakan ^a   Alihanoǧlu, Yusuf Izzettin ^a   Sönmez, Osman ^a   Ayhan, Selim Suzi ^a   Gök, Hasan ^a  

^a SELCUK UNIVERSITY   (Turkey)

Author keywords

Albuminuria; Blood pressure monitoring, ambulatory; Echocardiography, doppler; Metabolic syndrome X; Ventricular dysfunction, left etiology

Indexed keywords

ALBUMIN; LIPID;

ADULT; ALBUMINURIA; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; BODY MASS; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC DYSFUNCTION; FEMALE; HEART INJURY; HEART LEFT VENTRICLE MASS; HEART PERFORMANCE; HUMAN; KIDNEY INJURY; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTIVARIATE ANALYSIS; REGRESSION ANALYSIS; SMOKING; TARGET ORGAN; TISSUE DOPPLER IMAGING; URINARY EXCRETION;

ADULT; ALBUMINURIA; BLOOD PRESSURE; DIASTOLE; FEMALE; HEART RATE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; VENTRICULAR DYSFUNCTION, LEFT;

EID: 75649099035     PISSN: 10165169     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Mulè G, Nardi E, Cottone S, Cusimano P, Volpe V, Piazza G, et al. Influence of metabolic syndrome on hypertension-related target organ damage. J Intern Med 2005;257:503-13.
2. Cuspidi C, Meani S, Fusi V, Severgnini B, Valerio C, Catini E, et al. Metabolic syndrome and target organ damage in untreated essential hypertensives. J Hypertens 2004;22:1991-8.
3. Palmieri V, de Simone G, Roman MJ, Schwartz JE, Pickering TG, Devereux RB. Ambulatory blood pressure and metabolic abnormalities in hypertensive subjects with inappropriately high left ventricular mass. Hypertension 1999;34:1032-40.
4. Verdecchia P, Schillaci G, Guerrieri M, Gatteschi C, Benemio G, Boldrini F, et al. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 1990;81:528-36.
5. Hoshide S, Kario K, Hoshide Y, Umeda Y, Hashimoto T, Kunii O, et al. Associations between nondipping of nocturnal blood pressure decrease and cardiovascular target organ damage in strictly selected community-dwelling normotensives. Am J Hypertens 2003;16:434-8.
6. Soylu A, Düzenli MA, Yazici M, Özdemir K, Tokaç M, Gök H. The effect of nondipping blood pressure patterns on cardiac structural changes and left ventricular diastolic functions in normotensives. Echocardiography 2009;26:378-87.
7. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome 2005. Available from: www.idf.org/webdata/docs/IDF- Meta-def-final.pdf.
8. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007;28:1462-536.
9. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations forquantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-67.
10. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977;55:613-8.
11. Reichek N, Devereux RB. Reliable estimation of peak left ventricular systolic pressure by M-mode echographic-determined end-diastolic relative wall thickness: identification of severe valvular aortic stenosis in adult patients. Am Heart J 1982;103:202-3.
12. Quinones MA, Waggoner AD, Reduto LA, Nelson JG, Young JB, Winters WL Jr, et al. A new, simplified and accurate method for determining ejection fraction with two-dimensional echocardiography. Circulation 1981;64:744-53.
13. Mulè G, Nardi E, Cottone S, Cusimano P, Incalcaterra F, Giandalia ME, et al. Impact of metabolic syndrome on left ventricular mass in overweight and obese hypertensive subjects. Int J Cardiol 2007;121:267-75.
14. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990;322:1561-6.
15. Arnlöv J, Evans JC, Meigs JB, Wang TJ, Fox CS, Levy D, et al. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation 2005;112:969-75.
16. Kikuya M, Ohkubo T, Asayama K, Metoki H, Obara T, Saito S, et al. Ambulatory blood pressure and 10-year risk of cardiovascular and noncardiovascular mortality: the Ohasama study. Hypertension 2005;45:240-5.
17. Sega R, Facchetti R, Bombelli M, Cesana G, Corrao G, Grassi G, et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation 2005;111:1777-83.
18. Pickering TG, Shimbo D, Haas D. Ambulatory blood-pressure monitoring. N Engl J Med 2006;354:2368-74.
19. Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, et al. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens 2002;20:2183-9.
20. Vyssoulis GP, Karpanou EA, Kyvelou SM, Adamopoulos DN, Deligeorgis AD, Spanos PG, et al. Nocturnal blood pressure fall and metabolic syndrome score in hypertensive patients. Blood Press Monit 2007;12:351-6.
21. Nagueh SF, Bachinski LL, Meyer D, Hill R, Zoghbi WA, Tam JW, et al. Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy. Circulation 2001;104:128-30.
22. Tei C, Ling LH, Hodge DO, Bailey KR, Oh JK, Rodeheffer RJ, et al. New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function - a study in normals and dilated cardiomyopathy. J Cardiol 1995;26:357-66.
23. Abhayaratna WP, Marwick TH, Smith WT, Becker NG. Characteristics of left ventricular diastolic dysfunction in the community: an echocardiographic survey. Heart 2006;92:1259-64.
24. Volpe M. Microalbuminuria screening in patients with hypertension: recommendations for clinical practice. Int J Clin Pract 2008;62:97-108.
25. Leoncini G, Ratto E, Viazzi F, Conti N, Falqui V, Parodi A, et al. Global risk stratification in primary hypertension: the role of the kidney. J Hypertens 2008;26:427-32.
26. Eguchi K, Schwartz JE, Roman MJ, Devereux RB, Gerin W, Pickering TG. Metabolic syndrome less strongly associated with target organ damage than syndrome components in a healthy, working population. J Clin Hypertens 2007;9:337-44.
27. Routledge F, McFetridge-Durdle J. Nondipping blood pressure patterns among individuals with essential hypertension: a review of the literature. Eur J Cardiovasc Nurs 2007;6:9-26.
28. White WB. Importance of blood pressure control over a 24-hour period. J Manag Care Pharm 2007;13(8 Suppl B):34-9.
29. Symeonides P, Koulouris S, Vratsista E, Triantafyllou K, Ioannidis G, Thalassinos N, et al. Both ramipril and telmisartan reverse indices of early diabetic cardiomyopathy: a comparative study. Eur J Echocardiogr 2007;8:480-6.
30. Slight SH, Joseph J, Ganjam VK, Weber KT. Extraadrenal mineralocorticoids and cardiovascular tissue. J Mol Cell Cardiol 1999;31:1175-84.
31. Motz W, Strauer BE. Left ventricular function and collagen content after regression of hypertensive hypertrophy. Hypertension 1989;13:43-50.
32. Gottdiener JS. Left ventricular mass, diastolic dysfunction, and hypertension. Adv Intern Med 1993;38:31-56.